Wednesday, July 8, 2026

pharma · Paroxysmal Nocturnal Hemoglobinuria (PNH) · Paroxysmal Nocturnal Haemoglobinuria (PNH) · AKTX

Akari Therapeutics

News and analysis for Akari Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

London, GB HQ
16 Employees
Public company Type
AKTX · NYSE Ticker
Company details
Status
Public
HQ
London, GB
Employees
16
Programs
9
Drugs
0
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Akari Therapeutics — regulatory, clinical, and market coverage.

News and analysis for Akari Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Akari Therapeutics yet.

Back to company overview →